Jump to content

AstraZeneca share price: Q2 earnings preview


Recommended Posts

Astrazeneca Q2 revenue is expected to show strong growth, although an increased cost base will pressure underlying earnings.

AstraZenecaSource: Bloomberg
 
 Shaun Murison | Senior Market Analyst, Johannesburg | Publication date: Tuesday 27 July 2021 

When are the AstraZeneca results?

AstraZeneca, the biopharmaceutical company, earnings release date is scheduled for 27 July 2021. The scheduled results will cover the groups second quarter (Q2) and half-year earnings.

What to expect from AstraZeneca results?

While a large Covid-19 vaccine rollout will have boosted revenue for the group, it would have done little for underlying earnings due to the company selling the product as a non-profit item.

Consensus estimates derived from Refinitiv data arrives at the following expectations for Q2 of 2021:

  • Revenue $7.530 billion (+20%) year on year (YoY)
  • Earnings before interest tax depreciation amortisation (EBITDA) $2.233 billion (-10.75% YoY)
  • Earnings per share (EPS) $0.93 (-3.01% YoY)

What is expected to be accretive to future earnings for the group (although may weigh in the short term) is the groups acquisition of biopharmaceutical business Alexion, which was concluded on 21 July 2021, shortly after the reporting quarter.

Find out more on how to buy, sell and short AstraZeneca shares

How to trade AstraZeneca results

A Refinitiv poll of 29 analysts maintain a long-term average rating of ‘buy’ for AstraZeneca (as of 26 July 2021), with 10 of these analysts recommending a strong buy, 16 recommending a buy, 1 hold, 1 sell and 1 strong sell recommendation on the stock.

AstraZeneca broker ratingsSource: IG

AstraZeneca share price – technical analysis view

AstraZeneca chartSource: IG charts

 

The share price of AstraZeneca continues to trade in an uptrend which has been in place since the beginning of 2021. The price has however started to correct from near-term highs.

Traders respecting the longer-term uptrend will prefer to keep a long bias to trades targeting a retest of the 8770 level, provided that the price does not move to break the confluence of both trend line and horizontal support at the 7800 level. A break of the 7800 level would instead suggest the uptrend to be broken.

In summary

  • AstraZeneca results are scheduled for release on 27 July 2021
  • Q2 revenue of $7.530 billion is expected
  • Q2 EBITDA of $2.223 billion is expected
  • EPS of $0.93 is expected
  • The average broker rating for AstraZeneca is ‘buy’
  • The share price of AstraZeneca is currently in a short term correction of a longer-term uptrend
Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • image.png

  • Posts

    • Bitcoin's rally is fueling gains across the market. Here are 3 altcoins with breakout potential:   Fetch.ai (FET): Bullish triangle pattern hints at a surge to $3.48 or even $5 by month's end. Floki (FLOKI): Recent breakout suggests a climb to $0.00045, capitalizing on meme coin momentum. **** (****): Inverted head & shoulders pattern forming, potentially driving price to $0.000071.   Could these be the next big crypto moonshots, or are they headed for a fall? Read the full article here for a more detailed analysis of each altcoin, including charts and technical indicators: https://coinpedia.org/price-analysis/memecoins-for-3x-profits-by-the-end-of-may/
    • Bitcoin (BTC) is breaking out, surging nearly 10% in a week and reclaiming the $67,000 level. This bullish trend has ignited questions about whether a new all-time high, or even the psychological barrier of $100,000, is within reach. Key Points:   Post-Halving Rally Echo: The current surge resembles past post-halving rallies, where Bitcoin's price historically jumps after its block reward gets reduced. This scarcity could be driving the current upswing.   Technical Indicators Support Bullish Outlook: Daily charts hint at a potential breakout from a resistance trendline, signifying the end of a corrective phase. Additionally, bullish signals emerge from technical indicators like VI lines and ADX. Fibonacci Levels Suggest Six-Figure Target: Based on Fibonacci levels, a significant price increase is on the table. If the momentum holds, a moonshot to $100,000 this year seems achievable. However, some analysts predict a more conservative target of $77,842 by Q2 2024.   AI Predicts Bullish Q2, But How Bullish?:  The analysis incorporates predictions from ChatGPT. While many expected a bullish forecast, ChatGPT surprised with a potential rally to a staggering $87,613 by the end of June! Is Bitcoin on the cusp of a historic bull run, or is this just a temporary spike?   Read the full article here for a deeper dive into the technical analysis, expert opinions, and a closer look at the AI's prediction:  https://coinpedia.org/price-analysis/chatgpt-predicts-how-high-can-bitcoin-price-rally-in-q2-2024/    
    • Pepe, the meme coin, has dropped 12% after reaching record highs earlier this week. This has investors wondering if it's a good time to buy. Why Did Pepe Surge? The Pepe price jump was linked to the return of an online personality known as "Roaring Kitty," who was a key figure in the meme stock craze of 2021. This triggered excitement around Pepe, similar to what happened with meme stocks back then. Is Now the Time to Buy Pepe? Experts say it might be a bit early. While the price has dropped, it's still significantly higher than usual. Instead of buying now, investors might want to wait for a retest of a specific price point (around $0.00000920) which could offer better buying opportunities. Why Are Some Investors Still Bullish on Pepe? Despite the recent drop, many believe Pepe has room to grow. Here's why: Popularity: Pepe is gaining popularity, which could drive the price up. Market Cap: Compared to other meme coins like Dogecoin and Shiba Inu, Pepe's market cap is still relatively low. This means there's potential for significant growth.  
×
×
  • Create New...
us